Xolajam

DESCRIPTION: 
Xolajam is the combination of a topical carbonic anhydrase inhibitor and a topical beta-adrenergic receptor blocking agent. 

INDICATIONS AND USAGE:  
Xolajam is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target IOP determined after multiple measurements over time). 

HOW SUPPLIED:  
Xolajam Sterile Ophthalmic Solution, 5 ml in LDPE bottles.